A recent study indicates that patients who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.
Published data in a major health publication demonstrates that while overweight people can lose about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month after stopping.
"People purchasing such medications need to be cognizant of the danger of rapid rebound weight gain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of regain implies a reversion to starting weight within about 18 months.
Analyzing Therapies
The research, which examined dozens of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that people who lose weight through lifestyle changes alone typically have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Rapid Regain
Nutrition scientists propose the mode of action of the injections is key to understanding the amplified rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels far above than normal could lead to the system to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication leads to appetite is uncontrolled, making overeating far more likely."
An Ongoing Issue?
The NHS advise the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, given the likelihood of relapse, the therapy is often ongoing.
This view is reinforced by pharmaceutical companies, who state that the results "underscore the persistent nature of obesity," comparing it to managing conditions like hypertension.
User Testimonies
Users who have come off the jabs explain a intense return of hunger.
"I experienced a switch flipping and you become ravenous," recalled a patient.
This difficulty is exacerbated if patients have not adopted lasting lifestyle or habit modifications during therapy.
Significant Use
Recent estimates show that a significant number of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is higher among females compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while the jabs are effective agents for shedding pounds, they are not a permanent solution and maintained weight loss hinges on ongoing lifestyle management.
